Induction of immune tolerance by using methotrexate
US11672802B2 · kind B2 · utility
1Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Mar 24, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for reducing undesired immune responses, such as anti-drug antibody (ADA) responses and other T- and/or B-cell-mediated immune responses, in patients by using treatment with methotrexate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.